Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
NCT01748448Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2012
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of vitamin d in Malignant Melanoma (MM), sponsored by UZ Leuven. Started Dec 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT01748448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748448.